Research & Partnership Highlights
(FY22–Present)
Research Pipeline
25 active research projects
4 compounds have translated to Phase I clinical trials
Intellectual Property
Over 140 U.S. issued patents
More than 350 published patent applications
Collaborations
36 active partnerships with biotech and pharmaceutical companies
* Types include partnered research, co-funded projects, and shared target discovery
Funded Research Projects
35 research initiatives funded since FY22
* Total projected funding exceeds $52 million
Estimated Partnership Costs
Average cost per partnership ranges from $325K to $350K
(all inclusive)
View our Collaborations




































